Витрум

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Витрум

Quick Facts about Витрум

Property Description
Active ingredient 17 essential vitamins and minerals
Form Oral tablet (typically film-coated)
Pharmacological class Metabolic agent, Polyvitamin-mineral complex
Common use Nutritional support and deficiency prevention
Origin Synthetic/Derived nutrients

What Type of Preparation is Витрум? (Identity and Classification)

The preparation Витрум is classified as a polyvitamin-mineral complex, functioning pharmacologically as a metabolic agent that supplies a wide array of essential micronutrients for systemic processes. It is defined as a comprehensive combination product, integrating both organic vitamin compounds and critical inorganic mineral elements into a single oral tablet formulation. Products containing three or more vitamins and minerals are generally classified as multivitamin/mineral supplements.

The product is commercially established, often positioned to support adult patients with complex nutritional needs. The consistent form, typically a film-coated tablet, is designed for convenient ingestion, ensuring reliable systemic absorption via the oral route of administration.


Composition of Витрум: A Comprehensive Micronutrient Panel

Витрум contains 17 active components, spanning essential fat-soluble vitamins (A, E, and the D analogue Dihydrotachysterol) alongside the complete spectrum of water-soluble B-group vitamins, including Thiamine Hydrochloride (B1), Riboflavin (B2), Nicotinamide (B3), Pyridoxine Hydrochloride (B6), Folic Acid (B9), Cyanocobalamin (B12), and Biotin (H). Complementing these are key minerals such as Calcium, Phosphorus, and Magnesium, along with trace elements like Zinc Sulfate and Nickel Sulfate. The inclusion of Beta Carotene provides a source of provitamin A and an antioxidant property.


General Purpose: Nutritional Support and Deficiency Management

The primary purpose of the Витрум complex is the prevention and management of hypovitaminosis and mineral deficiency states. This formulation acts by ensuring the presence of fundamental cofactors necessary for the body's enzyme systems. Multivitamin/multimineral supplementation can assist in raising intake levels for numerous essential nutrients to the required daily amounts, supporting broad nutritional goals. As such, the preparation is used for broad nutritional support, making it a typical choice for individuals seeking to compensate for nutrient gaps resulting from an unbalanced diet or increased physiological demand.

Regulatory References

  1. National Institutes of Health (NIH) recognizes as a common category of dietary intake support

What side effects are possible with Витрум?

Possible Side Effects and Safety Information

The safety profile for this polyvitamin-mineral complex, as documented in official government regulatory sources, establishes a range of possible adverse reactions primarily classified by the systems they affect and their frequency.

Documented Adverse Reactions and Frequencies

The most commonly reported adverse reactions are related to the Gastrointestinal System, including general upset stomach, constipation, and diarrhea. These effects are frequently documented as temporary and often resolve as the body adjusts to the preparation.

Adverse reactions affecting the Skin and Subcutaneous Tissue include documented occurrences of rash, itching, and flushing. More serious effects on the Immune System, such as severe hypersensitivity (anaphylaxis), are classified as rare events and require immediate attention.

Critical Safety Considerations

The official safety information highlights specific, non-dosing related constraints:

  • Pediatric Safety: Due to the iron component, the U.S. FDA mandates a strong warning, noting that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age.
  • Nutrient Interaction: The folic acid component carries the safety risk of potentially masking the hematological symptoms of an underlying Vitamin B12 deficiency (pernicious anemia). If the underlying deficiency is not addressed, this masking can progress to serious, irreversible neurological damage.
  • Functional Limitations: The complex may interfere with the absorption of certain other co-administered medications (e.g., specific antibiotics, thyroid medications) and can potentially affect the results of some laboratory tests.

Overdose and Emergency Response

Витрум Overdose and when to seek help

The official regulatory profile for this polyvitamin-mineral complex indicates that overdose may lead to severe systemic toxicity, primarily due to the accumulation potential of the fat-soluble components, Vitamin A and Vitamin D. Toxicity is generally associated with large single-event ingestions or chronic excessive intake, leading to potential hypervitaminosis.

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Overdose may present with gastrointestinal disturbances (nausea, vomiting, abdominal pain), CNS effects (headache, irritability), and signs of hypercalcemia (polyuria, thirst, muscle weakness) and hypervitaminosis A (visual disturbances, skin exfoliation).
Physiological systems affected (as stated in label) Central Nervous System (CNS), Renal System, Gastrointestinal System, and Fluid/Electrolyte Balance.
Dose-related or exposure-related factors (if applicable) Toxicity risk is primarily driven by large acute ingestions or chronic excessive intake of the Vitamin A and D components.
Population-specific overdose notes (if applicable) Pediatric patients are at heightened risk following accidental ingestion. Patients with pre-existing renal impairment are cited for increased risk of mineral accumulation and hypercalcemia.
Emergency-response statements (as written in official documents) Regulators mandate to seek immediate medical attention or contact a poison control center immediately upon any suspected overdose. Discontinuation of the product is the required first action.
When immediate medical help is required (label-derived phrasing only) Urgent medical help is required immediately upon any suspected overdose or following the onset of severe systemic signs.

Overdose Classifications (High-Level)

Classification Official Regulatory Statement
Severity classification (as defined in official documents) Overdose risk is classified as potentially leading to severe systemic toxicity, including renal and neurological complications.
Regulatory basis (EMA / FDA / etc.) Regulatory requirements are based on the documented toxicological profiles of the high-risk individual components.
Overdose-context constraints (as defined in official documents) Management is constrained to symptomatic and supportive measures as no specific antidote is known for the complex formulation.

Resulting Overdose Structure

Official overdose statements:

  • Documented severe outcomes include the potential for increased intracranial pressure and renal complications (e.g., nephrocalcinosis) stemming from hypervitaminosis.
  • Management procedures officially described include symptomatic and supportive treatment and mandatory hospital monitoring of serum calcium, renal function, and electrolytes.

Connection to the overall overdose profile (3 sentences): The official regulatory documents define the overdose profile primarily through the systemic toxicities of its fat-soluble components. This profile establishes clear thresholds for required emergency action—which is immediate upon suspicion—and mandates specific clinical procedures such as product discontinuation and hospital monitoring. The structure strictly adheres to detailing documented manifestations and the precise conditions under which urgent medical help must be sought, exactly as stipulated in government labeling.

Therapeutic Uses of Витрум

What Витрум Treats: Main Uses and Benefits

The primary use of the Витрум polyvitamin-mineral complex is to provide broad nutritional support, focusing on the prevention and management of essential nutrient deficiencies and the resulting symptomatic burden. Multivitamin/mineral supplements, which belong to this category, are generally used to increase the daily intake of nutrients and help fill nutritional gaps when diet alone is insufficient.

The preparation is used in the context of managing symptom clusters that create noticeable physiological strain, particularly persistent fatigue, general weakness, and diminished physical work capacity often linked to poor nutrient status.

“It is commonly used to help with symptoms related to systemic imbalance and may be part of symptomatic management to support the body's efforts to address the impact of nutrient shortfalls.”

Clinical uses for the preparation include the management of established hypovitaminosis and mineral insufficiency states, and offering support during phases of intense physical activity, high mental workload, or key life stages such as pregnancy and nursing. This supportive role is intended to assist with day-to-day comfort and provide supportive relief when symptoms interfere with routine activities.

Quick Fact: Support for Fatigue
Primary Context Used when symptoms of weakness and low vitality are linked to chronic nutritional gaps.
Core Benefit Contributes to improved comfort and assists with maintaining functional stability during symptomatic periods.

Eligibility and Restrictions for Use

The official eligibility profile for the Витрум polyvitamin-mineral complex strictly defines populations who are permitted or prohibited from using the preparation, based on patient factors, age, and pre-existing conditions.

Eligibility Status Applicable Population/Condition
Contraindicated Patients with known Hypersensitivity to any component.
Contraindicated Patients with established Hypervitaminosis A or Hypervitaminosis D.
Contraindicated Patients with pre-existing Hypercalcemia (high calcium levels).
Not Recommended The standard complex is typically contraindicated in children and adolescents below the labeled minimum age (which may be 12 or 18 years, depending on the formulation).
Not Recommended Pregnancy and Lactation are often listed as restrictions or contraindications for the general complex, requiring specific guidance, though specialized prenatal versions exist.
Conditional Use Patients with severe hepatic impairment or severe renal impairment are restricted from use or must proceed with extreme caution [RxList]. Use is also conditional for those with specific metabolic disorders or an increased risk of Thrombus Formation.

The regulatory framework restricts use primarily based on the risk of exacerbating pre-existing nutrient overloads or compromising elimination routes due to organ dysfunction. Eligibility is generally reserved for adults seeking nutritional support.

What should I know about interactions with other medicines?

The official regulatory interaction profile for Витрум is primarily defined by the ability of its mineral components (multivalent cations like Calcium, Iron, and Zinc) to interfere with the absorption of other medications and by the pharmacodynamic activity of certain high-dose vitamins.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Medicine / Class Documented Interaction Mechanism Regulatory Outcome
Tetracyclines & Fluoroquinolones Absorption Interference (Chelation) by multivalent cations. Reduced systemic exposure and efficacy of the antibiotic.
Levothyroxine Absorption Interference by Calcium and Iron. Reduced efficacy of the thyroid hormone, requiring strict timing rules.
Warfarin (Vitamin K Antagonists) Pharmacodynamic Antagonism by the Vitamin K component. Decreased anticoagulant effect and increased clotting risk.
Levodopa Pharmacodynamic Antagonism by Pyridoxine (Vitamin B6). Reduced efficacy of Levodopa.

Administration Constraints

Co-administration with medications susceptible to chelation (such as Levothyroxine, Tetracyclines, and Fluoroquinolones) is restricted and requires a mandatory timing separation. To mitigate the risk of reduced exposure of the interacting drug, it must be administered at least 2 hours before or 4 hours after the polyvitamin-mineral complex, as explicitly stated in official regulatory documents.

Mechanism of Action

How Витрум Works

Витрум exerts its physiological influence by engaging several distinct molecular and cellular mechanisms that influence pathway dynamics and cellular signaling. The drug's mechanism of action spans key signaling processes to modulate pathway activity.

Modulation of Receptor-Mediated Signaling

This mechanistic domain covers the drug's action within systems involving receptor- or enzyme-mediated signaling, where it selectively modifies early molecular steps. The mechanistic consequence is a dampening of signaling, which restricts initial receptor-mediated output.

Regulation of Dysregulated Processes

This domain involves the influence of Витрум on processes driven by distinct signaling patterns. It engages mechanisms that adjust overactive or dysregulated processes. This results in alterations to pathway output that shape the drug’s pharmacological profile.

Influence on Downstream Signaling Cascades

Витрум modifies mid-to-late steps in signaling sequences by initiating or suppressing cascades that lead to downstream effects. This action is relevant in pathways where multiple layers of activation occur, which modifies the influence of high mediator concentrations and shifts pathway feedback kinetics.

Dosage and Administration Information

Instruction Map: How to Use Витрум — Standard Administration Guidelines

This map provides the standardized administration protocol for the Витрум polyvitamin-mineral complex, consistent with common standards for this class of oral supplements.

Category Standard Guidance
Route of administration Oral (by mouth).
Dosing schedule One (1) film-coated tablet.
Timing in relation to meals Recommended to be taken with a meal or immediately after a meal.
Preparation requirements None; the tablet must be swallowed whole and intact.
Age-group administration rules The standard regimen is for adults. Specific guidance is provided for use during pregnancy and lactation (nursing) due to altered requirements.
Missed-dose rules Standardized guidance advises resuming the regular schedule with the next planned dose and not taking a double dose to compensate.
Special procedural conditions The film coating mandates swallowing the tablet whole with an adequate amount of water.

Instruction Classifications (High-level)

Category Classification
Administration method type Oral.
Frequency pattern Daily (Once per day).
Regulatory basis Governed by standardized protocols for multivitamin-mineral products.
Use-context constraints Must be associated with food intake and for a defined course or period of nutritional need.

Resulting Procedural Structure

Typical step sequence:

  • Ingest the unit dose of one tablet.
  • Take the tablet whole, without chewing or crushing.
  • Consume the tablet with or immediately following a meal.
  • Administer the dose once daily.

Connection to the overall use protocol

The standard instructions establish a consistent and standardized oral administration protocol, defining a once-daily intake that must be concurrent with food consumption to optimize component delivery. This protocol governs the unit dose and frequency for general use, with specific provisions detailing the adjustments necessary for periods of heightened demand, such as pregnancy.

Recent Clinical Evidence

Research evidence / Overview of studies for Витрум


Evidence Overview: Correcting Nutrient Deficiencies and Status

Multivitamin-mineral (MVM) complexes, such as Витрум, was studied for outcomes related to systemic or functional imbalance, specifically focusing on nutritional status. Research examined whether taking these preparations could influence the levels of essential vitamins and minerals in the blood and help people meet their recommended daily intake. Large-scale population health data analyses (cross-sectional surveys) along with shorter-term randomized controlled trials (RCTs) was observed in these research contexts.

Research highlights changes measured during the study period and indicates MVM use was associated with observed differences in biochemical deficiency states in the study groups.

However, the evidence remains limited in addressing whether the correction of a low nutrient level in the blood is associated with differences in the incidence of major long-term diseases or conditions in otherwise healthy populations. The findings describe group patterns, not personal outcomes, and do not determine whether an individual will respond similarly if they are not already experiencing a deficiency.


Research on Cognitive Function and Fatigue

Research was evaluated in specific populations, primarily older adults, to see if MVM use was associated with measures of brain function, such as memory and overall cognition. These studies often involved long-term, large-scale RCTs where participants were observed in defined time intervals, sometimes spanning several years. Researchers monitored outcomes using standardized assessments of global cognitive function scores and specific tests for memory and recall.

Findings were mixed across these long-term studies. Some research suggests a modest pattern of association between MVM use and certain cognitive measures, particularly in specific memory domains. The consistency of these patterns across all trials remains low, and the magnitude of the changes measured on the test scores is not fully established, with certainty remaining low regarding how symptoms evolved in the observed populations. Separately, research explored outcomes related to physical discomfort, specifically self-reported fatigue and physical capacity, often in short-term intervention trials. Studies report how symptoms evolved in the observed populations, but findings were mixed, and consistent changes in physical capacity measures were not widely observed.

There is limited information for long-term outcomes regarding both cognitive function and sustained physical capacity following MVM use. Furthermore, evidence quality varies across studies concerning effects on mood or general energy levels, and sample sizes were modest in many of the trials focusing on fatigue.

Key Studies & References

  1. Dietary Supplement Fact Sheet: Multivitamin/mineral Supplements - National Institutes of Health Office of Dietary Supplements (NIH ODS)

Frequently Asked Questions (FAQ)

Common questions about Витрум (FAQ)


Q: Is it true that Vitrum helps improve skin and hair condition?

Official information for specific formulations, such as Vitrum Beauty, describes the preparation as participating in collagen formation and other processes. This activity is cited as contributing to the observed improvement of skin, nail, and hair structure. The effects and benefits are generally specific to the specialized components of the particular formulation.


Q: How does Vitrum Prenatal differ from regular Vitrum?

The Prenatal Plus formulation is a specialized complex with a composition tailored to specific nutritional requirements. It is officially indicated for replenishing vitamins and minerals during the periods of pregnancy, postpartum, and lactation. The complex is defined to help reduce the risk of conditions like iron-deficiency anemia and iodine deficiency during these times.


Q: Is it true that Vitrum is an American brand?

The original brand was historically associated with the U.S. corporation Unipharm, Inc. However, official regulatory and manufacturing information indicates that the product line may be manufactured or distributed by various entities in different countries, which can include the U.S., Czech Republic, and Belarus, depending on the specific product formulation and region.


Q: Why does urine change color when taking Vitrum?

A pronounced yellow or bright orange coloring of the urine is a common and non-harmful effect that may be observed while taking the complex. This change is related to the body processing and excreting Riboflavin (Vitamin B2), which is one of the water-soluble components of the product.


Q: If taking Vitrum for a long time, can there be an overdose?

Regulatory safety information notes that long-term use in doses higher than officially recommended may potentially lead to an intensification of side effects. In rare instances, this can result in conditions like hypercalcemia (excess calcium) or hypercalciuria. The evaluation of continuing administration for subsequent courses is typically performed by a medical professional.


Q: Does Vitrum help strengthen immunity?

While the core product supports general nutritional health, one specific formulation, Vitrum Immunactive, is officially classified and labeled as a Biologically Active Supplement (BAA) designed to support the body's immune function. The officially stated purpose varies depending on the specific product line.


Q: Is Vitrum available in a chewable form?

Yes, product registration documents confirm that certain specialized formulations in the Vitrum line are available as chewable tablets. This form is typically reserved for children's complexes (Junior) or specific single-vitamin products.


Q: Can Vitrum only be taken in winter?

Official guidance defines the use of the complex by a specified course duration (e.g., one month or three months) that may be repeated as necessary. The intake is not restricted to a specific time of year or season, but rather relates to an individual's nutritional needs or status.


Q: Should Vitrum be taken constantly or in courses?

Official product instructions for various formulations recommend a defined course of use, which may range from one to three months. The duration of the course is based on regulatory guidance. The criteria for initiating repeat courses is typically evaluated by a medical professional.


Q: Is Vitrum suitable for the elderly?

The standard complex is generally directed at the adult population. However, specific product lines, such as Vitrum Vitality 50+, are formulated and officially labeled specifically for older adults, reflecting potentially altered nutritional needs in this population.


Q: Does the composition of Vitrum differ for men and women?

Yes, the product line includes specific formulations that have compositions tailored and labeled separately for adult men and adult women. These gender-specific complexes are formulated to align with documented differences in nutritional requirements.


Q: Will Vitrum help with constant fatigue?

Research has included studies that explored outcomes related to physical discomfort and self-reported fatigue. However, findings from these studies regarding consistent, measurable changes in physical capacity were mixed and not widely observed across all available trials.


Q: Should Vitrum be taken in the morning or evening?

General regulatory instructions specify taking the complex once daily with a meal. Official product instructions for some specific formulations further suggest taking the tablet during the first half of the day, concurrent with or immediately following a meal.


Q: Can Vitrum cause insomnia?

Insomnia (difficulty sleeping) has been documented as a possible adverse reaction for specific formulations in the product line. This is typically observed in complexes that include components intended to influence the Central Nervous System (CNS).


Q: Are there age restrictions for taking Vitrum?

Yes, there are age restrictions defined in the official labeling. The standard adult complex is generally not recommended for children and adolescents below a specified minimum age (e.g., 12 or 18 years). Separate junior formulations are available and specifically labeled for children over a certain age.


Q: Can Vitrum be taken if I have diabetes?

While specialized, non-prescription formulations exist that are designed for nutritional support for individuals with diabetes, official labeling for some product forms notes that they may contain sugar or artificial sweeteners like aspartame. This is a factor noted for consideration in glucose management.


Q: What does 'biologically active supplement' mean for Vitrum?

The formal regulatory classification for many formulations in certain jurisdictions is that of a Biologically Active Supplement (BAA). This classification status differs from that of a registered pharmaceutical drug and affects the regulatory standards applied to its labeling and claims.


Q: What is the maximum time Vitrum can be taken without a break?

The officially recommended course duration varies depending on the specific formulation, often ranging from one month to three months. The evaluation for continuous administration or subsequent courses is typically performed by a medical professional, considering individual nutritional status.


Q: Can Vitrum be taken if I am prescribed other vitamins?

Taking this complex concurrently with other vitamin preparations carries a potential risk of exceeding the recommended daily allowance for specific nutrients. Official safety documents particularly draw attention to the potential risks associated with excessive intake of fat-soluble vitamins (hypervitaminosis) or iron.


Q: What are the general expectations from taking Vitrum?

The general expectation, as established in the official purpose, is the prevention and management of hypovitaminosis (vitamin deficiency) and mineral deficiency states. The complex is defined as providing essential micronutrients necessary for the body's enzyme systems and overall broad nutritional support.


Q: What studies have been conducted on the safety of Vitrum?

The safety profile for the product is established and maintained through official regulatory surveillance. This process involves the documentation of reported adverse reactions, adherence to mandated warnings (such as the FDA iron warning), and the ongoing post-marketing monitoring of safety data.


Q: Can Vitrum reduce the effectiveness of other medicines?

Yes, regulatory documents detail specific pharmacokinetic and pharmacodynamic interactions. Mineral components, such as Calcium and Iron, can reduce the systemic exposure and effectiveness of co-administered medications like Levothyroxine and certain antibiotics by interfering with their absorption.


Q: Does Vitrum help only with vitamin deficiency?

The official purpose of the complex includes both the prevention and the management of deficiency states. This suggests the product is used to support broad nutritional goals and prevent potential deficiencies from occurring, not solely to treat an already established deficiency.

How should Витрум be stored and disposed of?

How to Store and Dispose of Vitrum

Official regulatory labeling dictates strict conditions for the storage and disposal of Vitrum (Multivitamin with Minerals).

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 20 C and 25 C (68 F and 77 F).
Protection Keep the container tightly closed to protect the tablets from moisture.
Container Must be stored in the original container.
Child Safety Keep this product out of the reach of children.

Disposal

Any unused or expired medicine must be disposed of according to local regulations. This instruction ensures the proper handling and discarding of the polyvitamin-mineral complex.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Витрум found in:

A-Z Index: